Reirradiation with stereotactic body radiotherapy for primary or secondary lung malignancies: Tumor control probability and safety analyses

医学 放射外科 核医学 剂量分馏 放射治疗 原发性肿瘤 放射科 内科学 癌症 转移
作者
Huanhuan Wang,Yuan Chen,Xin Liu,Nicholas G. Zaorsky,Kyle Mani,Zhimin Niu,Bo-Yu Zheng,Hong-Yu Zeng,Yuanyuan Yan,Yan-Jin Li,Yuan He,Chao-Zhi Ji,Bing‐Sheng Sun,Maobin Meng
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:187: 109817-109817 被引量:4
标识
DOI:10.1016/j.radonc.2023.109817
摘要

Reirradiation with stereotactic body radiotherapy (SBRT) for patients with primary or secondary lung malignancies represents an appealing definitive approach, but its feasibility and safety are not well defined. The purpose of this study was to investigate the tumor control probability (TCP) and toxicity for patients receiving reirradiation with SBRT.Eligible patients with recurrence of primary or secondary lung malignancies from our hospital were subjected to reirradiation with SBRT, and PubMed- and Embase-indexed articles were reviewed. The patient characteristics, pertinent SBRT dosimetric details, local tumor control, and toxicities were extracted. The logistic dose-response models were compared for TCP and overall survival (OS) in terms of the physical dose and three-, four-, and five-fraction equivalent doses.The data of 17 patients from our hospital and 195 patients extracted from 12 articles were summarized. Reirradiation with SBRT yielded 2-year estimates of 80% TCP for doses of 50.10 Gy, 55.85 Gy, and 60.54 Gy in three, four, and five fractions, respectively. The estimated TCP with common fractionation schemes were 50%, 60%, and 70% for 42.04 Gy, 47.44 Gy, and 53.32 Gy in five fractions, respectively. Similarly, the 2-year estimated OS was 50%, 60%, and 70% for 41.62 Gy, 46.88 Gy, and 52.55 Gy in five fractions, respectively. Central tumor localization may be associated with severe toxicity.Reirradiation with SBRT doses of 50-60 Gy in 3-5 fractions is feasible for appropriately selected patients with recurrence of peripheral primary or secondary lung malignancies, but should be carefully considered for centrally-located tumors due to potentially severe toxicity. Further studies are warranted for optimal dose/fractionation schedules and more accurate selection of patients suitable for reirradiation with SBRT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
奋斗的雪曼完成签到 ,获得积分10
4秒前
粗心的飞槐完成签到 ,获得积分10
4秒前
LELE完成签到 ,获得积分10
11秒前
了0完成签到 ,获得积分10
12秒前
apocalypse完成签到 ,获得积分10
17秒前
guhao完成签到 ,获得积分10
18秒前
指导灰完成签到 ,获得积分10
18秒前
善良的火完成签到 ,获得积分10
29秒前
优雅夕阳完成签到 ,获得积分10
31秒前
Jasper应助光亮的自行车采纳,获得10
31秒前
miki完成签到,获得积分10
32秒前
量子星尘发布了新的文献求助10
33秒前
糖宝完成签到 ,获得积分10
40秒前
KX2024完成签到,获得积分10
43秒前
松松发布了新的文献求助20
46秒前
nusiew完成签到,获得积分10
46秒前
huiluowork完成签到 ,获得积分10
47秒前
陶醉的翠霜完成签到 ,获得积分10
47秒前
47秒前
冷静如松完成签到 ,获得积分10
54秒前
56秒前
浮云完成签到 ,获得积分10
57秒前
屈岂愈完成签到,获得积分10
58秒前
1分钟前
Pupil完成签到,获得积分10
1分钟前
偏偏意气用事完成签到,获得积分10
1分钟前
安安完成签到,获得积分10
1分钟前
cttc完成签到,获得积分10
1分钟前
Chnimike完成签到 ,获得积分10
1分钟前
1分钟前
红茸茸羊完成签到 ,获得积分10
1分钟前
年轻千愁完成签到 ,获得积分10
1分钟前
liu完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
Wanyeweiyu完成签到,获得积分10
1分钟前
Fury完成签到 ,获得积分10
1分钟前
风中幻梦完成签到,获得积分10
1分钟前
bigpluto完成签到,获得积分10
1分钟前
1分钟前
是谁还没睡完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022